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Sections 30(4) and 30(5) of the Companies Act 71 of 2008 (the Act) require disclosure of certain 
information in a company’s annual financial statements, including the remuneration, as defined 
in subsection (6), and benefits received by each director or individual holding any prescribed 
office in the company. Section 30(6) contains details of what the term ‘remuneration’ referred to in 
Sections 30(4) and 30(5) includes and is a very broad concept. Section 30(6)(e), read together with 
Section 30(4), requires the disclosure (per director) of ‘the value of any option or right given 
directly or indirectly to a director, past director or future director, or person related to any of them, 
as contemplated in Section 42’. Section 42 deals with options for the allotment or subscription of 
securities or shares of a company.
According to Steyn and Cairney (2016), very few companies actually disclose the value of long-
term incentive compensation, which includes share-based payments (SBPs), and generally these 
values need to be calculated by the users of financial statements, using the information published 
in the companies’ remuneration reports. According to Voller (2016), companies are not disclosing 
directors’ remuneration properly in their annual financial statements, as required by the Act. 
PWC (2015:13) has also found that ‘the overall level of long-term incentives … disclosure is not 
yet on par with global standards’.
The term ‘value’, as used in Section 30(6)(e), is not defined in the Act and its meaning is unclear. 
Scrutiny of some listed companies’ annual financial statements confirmed that companies interpret 
this disclosure requirement differently, with values varying between ‘gross’ values, such as fair 
value on grant date or annualised grant date fair values, to ‘net’ values, such as gains on exercise 
of share options only or of all share incentives exercised (or combinations thereof) (Dippenaar & 
Background: Sections 30(4) and 30(5) of the Companies Act 71 of 2008 (the Act) require, inter 
alia, disclosure of the remuneration received by each director in a company’s annual financial 
statements. Section 30(6) defines the term ‘remuneration’, which includes, inter alia, in Section 
30(6)(e) the ‘value’ of any option or right granted to a director, as contemplated in Section 42, 
which deals with options for the allotment or subscription of securities or shares of a company. 
It is uncertain what the intended meaning of the term ‘value’ is in this context and it is 
interpreted differently by different companies in practice.
Aim: The objective of this study was to understand the meaning of the term ‘value’ in Section 
30(6)(e) of the Act (including the date of measurement thereof), as intended by the legislature.
Setting: This article examined existing literature in a South African corporate and legislative 
environment.
Method: A non-empirical study of existing literature was conducted by performing a historical 
analysis within a South African context. A doctrinal research approach was followed.
Results: Possible interpretations of the term ‘value’ include the grant date fair value of the 
rights, the fair value at reporting date, the fair value on vesting date, the expense calculated in 
terms of the International Financial Reporting Standard on share-based payments, the gain on 
exercise of the rights and the intrinsic value on reporting date. It is submitted that the most 
likely meaning is the grant date fair value.
Conclusion: It was found that the meaning of the term ‘value’, for purposes of Section 30(6)(e) 
of the Act, is unclear and interpreted differently by different companies. It is, therefore, 
recommended that the wording of Section 30(6)(e) is amended to reflect the meaning intended 
by the legislature.
A critical analysis of the meaning of the term ‘value’ in 
Section 30(6)(e) of the Companies Act
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Steenkamp 2017). The uncertainty regarding which ‘value’ 
is required to be disclosed by the Act (including the 
measurement date and appropriate valuation method) and 
the inconsistent interpretations applied by companies reduce 
the comparability of companies’ annual financial statements 
for shareholders and other stakeholders. The objective of 
this study is to understand the meaning of the term ‘value’ 
as used in Section 30(6)(e) of the Act, including the date 
of measurement thereof, as intended by the legislature. There 
is currently no guidance available regarding the meaning 
of this disclosure requirement. The study can potentially 
highlight areas for improvement or, at the very least, for 
consideration by the Minister of Trade and Industry to clarify 
the meaning of the term ‘value’ in Section 30(6)(e) of the Act. 
The study can potentially also assist companies to understand 
the intended meaning when preparing the disclosure in their 
annual financial statements. This could enhance comparability 
of companies’ annual financial statements.
Research methodology
A non-empirical study of existing literature was conducted 
by performing a historical analysis within a South African 
context. A problem-based doctrinal research approach was 
followed, using interpretive and qualitative analysis. The 
following steps, as suggested by Hutchinson and Duncan 
(2012), were followed to solve the specific research problem:
•	 Assemble the relevant facts.
•	 Identify the legal issue at hand.
•	 Analyse the issue from a legal perspective.
•	 Study relevant background material such as dictionaries 
and journal articles.
•	 Locate primary research sources such as case law and 
legislation.
•	 Interpret, analyse, compare and combine all issues within 
the context.
•	 Reach a tentative conclusion.
This research objective was achieved by investigating the 
following:
•	 The meaning of the term ‘value’ as used in Section 30(6)
(e) of the Act (including the date of measurement 
thereof), by exploring the ordinary definition thereof and 
attempting to use logical reasoning in order to determine 
the most likely meaning, as there is no specific guidance 
available in this regard.
•	 The impact of the different possible interpretations of the 
term ‘value’ in Section 30(6)(e) of the Act on companies’ 
annual financial statements.
During the study, it was found that a possible interpretation 
of ‘value’ is ‘fair value’ (as discussed later). Different 
techniques could be applied to appropriately determine a 
fair value. It is, however, not in the scope of this study to 
evaluate or prescribe a specific valuation technique.
The study is structured as follows: a brief discussion of 
the relevant aspects and principles of interpretation of 
legislation is presented. This is followed by a summary 
of all the possible literal (ordinary) meanings of the 
term ‘value’. Thereafter, the context of the wording in 
Section 30(6)(e) is explored in an attempt to determine the 
intended meaning of ‘value’. The possible interpretations 
of the term are discussed based on the types of SBPs 
in use and the regulatory frameworks that govern the 
disclosure of SBPs and a logical reasoning is applied in an 
attempt to determine the most likely meaning. A practical 
illustration of the impact of each possible interpretation on 
a company’s financial statement disclosure is presented 
and a conclusion regarding the most likely interpretation 
intended by the legislature, based on the literature study 
performed, is finally presented. Lastly, recommendations 
for the amendment of the existing wording in Section 
30(6)(e) are made and a future research opportunity is 
highlighted.
Interpretation of words used by the 
legislature
Principles of interpretation
The golden rule of interpreting statutes, subject to certain 
exceptions, is to apply the literal or ordinary meaning of the 
words used to determine the intention of the legislature, 
when the words are clear and unambiguous (Venter v R [1907] 
TS 910). In order to do so, the grammatical meaning of the 
words should be applied and dictionaries can be helpful in 
this regard. However, if a word is used in a technical sense, it 
has to be interpreted using its technical meaning, that is, its 
meaning within a specific trade, business or profession and 
not its ordinary meaning (De Ville 2000). Sometimes the 
intention of the legislature could be ascertained by referring 
to the context of the statute. This is usually when the ordinary 
meaning would be unreasonable or unconstitutional or lead 
to an ambiguity, absurdity or inconsistency (Devenish 1992; 
De Ville 2000; Ngcobo and Others v Salimba CC; Ngcobo v Van 
Rensburg 1999 [2] SA 1057 [SCA]). ‘Value’, as used in Section 
30(6)(e), is not so much ambiguous, but it is simply too vague 
to establish its true meaning in the context of the section. It is 
possibly even incomplete, as it does not specify what value 
should be used or on what date the value should be 
determined. In order to determine the context of a word, we 
refer to the scope and purpose of the specific section of the 
Act, as well as to its background (De Ville 2000; Jaga v Dönges 
NO 1950 [4] SA 653 [A] 662).
The literal meaning
There is no definition of ‘value’ in the Act; however, based on 
the dictionary meaning (Oxford English Dictionary 2017), 
‘value’ is commonly understood as, inter alia:
… the material or monetary worth of something; the amount at 
which something may be estimated in terms of a medium of 
exchange, as money or goods, or some other similar standard … 
[or] … the relative worth, usefulness, or importance of a thing 
or (occas.) a person; the estimation in which a thing is held 
according to its real or supposed desirability or utility.
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Other definitions include ‘the worth of a thing in money 
or goods at a certain time; market price’ (Webster’s New 
World College Dictionary n.d.) or ‘the balance between 
what a customer sees as the benefit to them of a product and 
the price they have to pay for it’ (Collins English Dictionary 
2017). A value can usually be expressed in a currency.
The technical meaning
Seeing that Section 30(6)(e) of the Act deals with the 
disclosure of directors’ remuneration and, specifically, 
with share incentives, ‘value’ is possibly used in a technical 
(accounting) sense in this context. International Financial 
Reporting Standards (IFRS), however, do not define ‘value’. 
IFRS (and the accompanying illustrative examples) usually 
do not even use the standalone term ‘value’, but specify the 
type of ‘value’ (Table 1). All of these different ‘values’ have 
different meanings, so they are either defined or IFRS explain 
how that value should be determined. Accounting standards 
were originally named International Accounting Standards 
(IAS) but newer standards (issued by the current standard 
setting body) are named ‘IFRS’. Collectively these standards 
(including IAS and IFRS standards) are also referred to as 
‘IFRS’. When reference is made to an individual standard, it 
is referred to as ‘IAS x’ or ‘IFRS x’ (x being the number of the 
specific standard).
When IFRS use the term ‘value’, without specifying which 
value, it is understood in its ordinary sense, namely the 
monetary worth of something. An example is when IFRS 
16 Leases (IFRS 16) refers to ‘asset … of low value’ (IFRS 16.6) 
or when IAS 20 Accounting for Government Grants and 
Disclosure of Government Assistance (IAS 20) refers to ‘those … 
which cannot reasonably have a value placed upon them’ 
(IAS 20.3). However, whenever IFRS require disclosure of a 
value, the standard would specify the type of value or how 
that value needs to be determined. Even when it appears to 
only refer to ‘value’ (as a standalone term), it has usually 
been specified earlier in that standard or section what was 
meant by ‘value’, for example a ‘fair value’, which is a term 
that is defined (IFRS Foundation 2016). Table 2 provides 
examples of such uses in IFRS. ‘Value’ is also usually 
understood to be a gross value and not a net value (such as, 
for example, the difference between two values – i.e. a gain), 
although exceptions exist.
Since the literal meaning of the term ‘value’ is too vague to 
understand what is meant in Section 30(6)(e) and IFRS do 
not clarify it either (from a technical sense), it is necessary to 
establish the context of the word within the statute.
The context of Section 30(6)(e)
The purpose of legislation provides context to determine the 
scope and intended effect of the law (Thornton 1996). In 
order to determine purpose, reference is made to Section 5 of 
the Act, which states that:
… this Act must be interpreted and applied in a manner that 
gives effect to the purposes set out in section 7 … [and] to the 
extent appropriate, a court interpreting or applying this Act may 
consider foreign company law.
Section 5 does not provide much assistance with interpreting 
Section 30(6)(e) either. Section 7 of the Act is considered 
to establish the purpose of the Act, but the purpose is 
too general in nature and not helpful in determining what 
could be meant by ‘value’ in Section 30(6)(e). The explanatory 
summary of the Companies Bill 2007 was also consulted, 
but again there was nothing specific in the commentary 
relating to annual financial statement disclosure or directors’ 
remuneration. In order to consider the background of the 
section, the history of the section was considered by referring 
to previous versions of the section.
Section 30(6)(e) was first introduced in the 2008 Act and 
there were no previous versions of this specific section. The 
Companies Act that applied before the 2008 Act became 
effective, was Companies Act 61 of 1973 (the 1973 Act). The 
1973 Act contained a Section 297(2A)(g)(i) which appears to 
be the predecessor of the current Section 30(6)(e) disclosure 
requirement. Section 297(2A)(g)(i), added in 1999, required 
the disclosure of:
TABLE 2: Some examples where ‘value’ is used as a standalone term in 
International Financial Reporting Standards.
Extract of wording used  
(own emphasis added)
Meaning of ‘value’ in this context
‘the net realisable value or recoverable 
amount … translated at the exchange 
rate at the date when that value was 
determined’ (IAS 21.25[b]).
Net realisable value or recoverable 
amount, as specified earlier in the 
sentence.
‘profits and losses on disposal of 
investments and changes in value of 
investments’ (IAS 26.35[b][ix]).
Actuarial present value, since this 
is what this standard specifies as 
the measurement basis of these 
types of items.
‘measure their value … indirectly, by 
reference to the fair value of the equity 
instruments granted’ (IFRS 2.10).
Fair value, as stated further in the 
same sentence.
‘recognise an additional expense for 
the excess value given, i.e. the 
difference between the cash paid and 
the fair value of the equity instruments 
that would otherwise have been 
issued, or the difference between the 
fair value of the equity instruments 
issued and the amount of cash that 
would otherwise have been paid, 
whichever is applicable’ (IFRS 2.43[c]).
Depending on applicability, the 
difference between the cash paid and 
the fair value of the equity instruments 
that would have been issued or the 
difference between the fair value of 
the equity instruments and the cash 
that would have been paid, as 
specified.
‘Option value is not a linear function of 
option term; value increases at a 
decreasing rate as the term lengthens 
… calculating estimated option value 
on the basis of a single weighted 
average life that includes widely 
differing individual lives would 
overstate the total fair value of the 
share options granted’ (IFRS 2.B20).
Fair value, as this entire section sets 
out to explain how to calculate fair 
value in this context.
IFRS, International Financial Reporting Standards.
TABLE 1: Terminology used in International Financial Reporting Standards to 
specify a type of value (listed alphabetically).
Actuarial present value Carrying value Economic value
Embedded value Entity-specific value Expected value
Fair value Intrinsic value Market value
Monetary value Net asset value Net realisable value
Nominal value Par value Present value
Redemption value Residual value Scrap value
Settlement value Surrender value Time value
Value in use – –
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… gains made on the exercise of share options, the gain being the 
difference between the price paid for the shares and the market 
price of the shares on the date of exercise, and that date being the 
date on which the director takes ownership of the shares and is 
entitled to dispose of them.
The original 1973 Act also required the disclosure of 
directors’ emoluments, but ‘emoluments’ were only later 
defined when Section 2A was added by the Companies 
Amendment Act 37 of 1999. The object of this was to improve 
disclosure and ensure more transparency, by enabling 
stakeholders to inspect the level of remuneration, without 
compromising an individual’s right to privacy (Republic of 
South Africa 1999b).
The provisions relating to directors’ remuneration 
disclosure, and specifically to SBPs, were clearly narrower 
and much more specific in the 1973 Act: it only related to 
share options, whereas in the 2008 Act it has been broadened 
to refer to ‘any option or right’ and it specifically required 
disclosure of the gain on exercise of the options. It was also 
more prescriptive, as it required the gains to be disclosed in 
table format. There was, however, no requirement to make 
the disclosure per director, as is the case in the 2008 Act. The 
use of the word ‘value’ in the new Act can be interpreted in 
various ways, from variations of gross values like a fair 
value on certain dates to net values like gains realised on 
exercise of share options.
Possible interpretations of ‘value’ based on the 
types of share-based payments in use
Examples of SBPs to employees and directors that are 
commonly used are, share options (a right to purchase 
shares at a predetermined exercise price), share appreciation 
rights (a right to receive a cash payment equal to the increase 
in value of shares from the grant date to the exercise date), 
phantom shares (a right to receive cash equal to the value of 
shares) and contingent or restricted shares (where the 
shares are granted for free) (Massie, Collier & Crotty 2014; 
Mavrodinov 2012; Steyn 2015). SBPs are classified as either 
equity-settled or cash-settled in terms of IFRS 2 Share-based 
Payment (IFRS 2), based on the nature of the SBP. Table 3 
provides a summary of what these schemes are typically 
classified as in terms of IFRS 2.
Table 4 provides a summary of the possible interpretations of 
‘value’, in the author’s opinion, and the types of SBPs to 
directors for which the values could be relevant. For the 
purposes of Table 4, two categories of SBPs are identified, 
namely options or share appreciation rights (including share 
purchase plans accounted for as options) and shares or 
phantom shares (including deferred bonus plans which are 
similar to the granting of shares). This classification is based 
on the fact that options and share appreciation rights could 
have an exercise date that is different from the vesting date, 
while shares or phantom shares usually only have a vesting 
date, which is also the exercise date.
Another possible interpretation of ‘value’ could include 
the fair value of the underlying shares (in the case of 
share options), although it is unlikely that this could be 
regarded as a ‘right’, as required by Section 30(6)(e). Similarly, 
it is unlikely that companies would interpret ‘value’ in the 
context of Section 30(6)(e) as meaning the amount payable to 
exercise the right (i.e. the exercise price). These two ‘values’ 
are rather the two items needed to calculate the gain on 
exercise that was required to be disclosed by the 1973 Act.
The author is of the opinion that the term ‘value’ in the 
context of Section 30(6)(e) does not imply a net value like a 
gain on exercise or an annualised value like the IFRS 2 
expense, otherwise the legislature would surely have 
provided clarification on how to calculate such a value, as 
was the case in the 1973 Act that provided details on how to 
calculate the gain. Surely if the term ‘value’ in Section 30(6)(e) 
was intended to still mean ‘gain on exercise’, the legislature 
would not have changed the wording in the Act completely 
from what it was in the 1973 Act. In the light of the ordinary 
meaning of ‘value’, it would make more sense for ‘value’ to 
be interpreted as a gross value, such as ‘fair value’. However, 
if the intention was for a ‘fair value’ to be disclosed, it is 
uncertain why the legislature did not use those specific 
words, as was the case in the other 14 places in the Act where 
specific mention is made of ‘fair value’ (inter alia in Section 
38(3)(b) relating to share issues). Not only is it unclear if a 
gross or net value is implied, but if a gross value should be 
disclosed, then it is uncertain on what date the value should 
be determined.
Possible interpretations of ‘value’ based on 
other regulatory frameworks
In an attempt to determine the most likely meaning of the 
term ‘value’ in Section 30(6)(e), other regulatory frameworks 
requiring disclosure of SBP to directors were consulted to 
establish which ‘values’ these sources require to be disclosed, 
regardless of whether it should be disclosed per director or in 
total. It is possible that the legislature intended for the same 
‘value’ to be disclosed. These other sources include IFRS 2 
and IAS 24 Related Party Disclosures (IAS 24) (IFRS Foundation 
2016), the King Report on Governance for South Africa 2009 
(King III) (IoDSA 2009) and the Johannesburg Stock Exchange 
(JSE) Listing Requirements (JSE Limited 2017). All companies 
registered in South Africa and that are required to be audited, 
need to comply with Section 30(4) of the Act, while only 
those listed or wishing to list on the JSE need to adhere to the 
listing requirements. Only those companies that are required 
to, by the Act, or those that choose to apply IFRS, need to 
comply with the requirements of IFRS 2 and IAS 24. The King 
code effective at the time of writing this article was King III. 
King IV replaces King III in its entirety and is effective for 
TABLE 3: IFRS 2 classifications of typical share-based payments to directors.
Type of share-based payment Equity-settled Cash-settled
Options X –
Share appreciation rights – X
Contingent or restricted shares X –
Phantom shares – X
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financial years beginning on or after 01 April 2017 (IoDSA 
2016). Compliance with King III is not legally binding. 
However, the JSE listing requirements require that companies 
apply certain principles of King III (JSE Limited 2017).
Below follows a discussion of the disclosure requirements of 
these other regulatory frameworks in an attempt to establish 
the possible meaning of the term ‘value’ that is used in Section 
30(6)(e). Consequently, disclosure requirements of narrative 
or qualitative information, or of quantitative information that 
is not currency values, such as for example the number of 
options granted or exercised, are excluded here.
IAS 24
IAS 24 requires disclosure of the SBP compensation to all 
key management personnel, including directors, in total 
(not per individual), that is, the current year IFRS 2 expense. 
This is a possible interpretation of the term ‘value’ in the 
context of Section 30(6)(e), but there are other more likely 
interpretations, as discussed below.
IFRS 2
The disclosure requirements of IFRS 2 are set out in Table 5. 
A discussion of whether these requirements are possible 
interpretations of ‘value’ in the context of Section 30(6)(e) is 
also included in Table 5.
JSE listing requirements
The JSE listing requirements require disclosure of the 
exercise price of each option or right outstanding at the 
beginning of the year, awarded during the year, exercised 
during the year and outstanding at reporting date. In 
addition, the price at which shares were issued or allotted 
(but not yet fully paid for) in terms of a share purchase or 
option plan (i.e. the exercise price) must also be disclosed.
It is unlikely that ‘value’ in the context of Section 30(6)(e) 
should be interpreted as the exercise price, as the amount 
payable to exercise the right does not constitute the value of 
the right. The wording of the JSE listing requirements also 
seems to imply that the disclosure requirements are different 
from those required by the Act: ‘in addition to complying 
with IFRS, Section 30 of the Act and paragraph 3.84 of the 
Listings Requirements, issuers are required to disclose the 
following information’ (JSE Limited 2017:par.8.63).
King III
The author is of the opinion that ‘value’ in Section 30(6)(e) of 
the Act should be interpreted to have the same meaning as 
that specified in King III. The introduction of the Act was the 
reason for a newer version of the King code (i.e. King III) and 
it seems as if the purpose of King III and the Act is to require 
disclosure of the same directors’ remuneration values:
TABLE 5: IFRS 2 disclosure requirements and applicability to Section 30(6)(e).
Disclosure requirement Possible interpretation of ‘value’ in 
the context of Section 30(6)(e)?
Weighted average exercise price of 
various categories of share options, 
such as those granted or exercised 
during the year, inter alia.
No, unlikely.
An amount payable will likely not be 
interpreted as the value of a ‘right’.
The range of exercise prices for 
outstanding options.
No, unlikely.
Same reason as above.
Weighted average share price, i.e. the 
market price (fair value) at exercise 
date for options exercised during the 
period.
No, unlikely.
The value of the underlying shares that 
can be purchased will likely not be 
regarded as a ‘right’.
For equity-settled instruments: the 
weighted average fair value on 
measurement date (i.e. grant date) of 
options or other equity instruments 
granted during the year.
Yes, possibly (grant date fair value).
However, a weighted average value 
would not be a good reflection of total 
‘remuneration’.
Incremental fair value granted as 
a result of modifications of 
equity-settled SBPs.
No, unlikely.
This requirement is too specific and 
would only arise in the limited 
circumstances where the terms of the 
SBP arrangement are modified. This 
does not constitute the full value of 
the right either, but is only an 
incremental value.
Total IFRS 2 expense. Yes, possibly.
Total carrying amount at reporting date 
of liabilities recognised in respect of 
cash-settled SBPs.
No, unlikely.
These values are only relevant for 
cash-settled SBPs, while Section 30(6)
(e) requires disclosure of ‘the value of 
any option or right’ which implies both 
cash-settled and equity-settled SBPs.
Total intrinsic value at reporting 
date of vested SBP-liabilities 
(i.e. cash-settled only).
No, unlikely.
Same reason as above.
SBPs, share-based payments.
TABLE 4: Possible interpretations of ‘value’.
Possible interpretations of ‘value’ Options/Share appreciation rights Shares/phantom shares Notes
Fair value on grant date. X X Determine fair value in terms of IFRS 2, i.e. of the equity 
instruments granted (if equity-settled) or of the rights 
(if cash-settled).
Fair value on reporting date. X
For both vested (but not yet exercised) 
and unvested instruments.
X
Only for unvested 
instruments.
For cash-settled share-based payments, this will be the value 
at which they are recognised in terms of IFRS 2.
Fair value on vesting date. X X Vesting date is exercise date for shares or phantom shares.
Value on exercise (similar to the 
gain on exercise as required for 
options only by the 1973 Act).
X X If equity-settled, calculate the gain as the difference between 
the market price (fair value) of the shares at exercise date 
and the exercise price, if any (else = 0). If cash-settled, this 
equals the actual amount paid.
IFRS 2 expense. X X If equity-settled, this equals the grant date fair value 
annualised over the vesting period. If cash-settled, the 
expense is the movement between the opening and closing 
balance of the liability raised (the liability is annually 
measured at the fair value at reporting date).
Intrinsic value on reporting date 
(i.e. the value of the instruments if 
they were to be exercised at the 
reporting date).
X
For both vested (but not yet exercised) 
and unvested rights.
X
Only for unvested 
instruments.
If equity-settled, the intrinsic value is the difference between 
the market price (fair value) of the shares at the reporting 
date and the exercise price, if any (else = 0). If cash-settled, 
this equals the actual amount payable if reporting date were 
the exercise date.
IFRS, International Financial Reporting Standards.
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Companies should provide full disclosure of each individual 
executive and non-executive directors’ remuneration, giving 
details as required in the Act of base pay, bonuses, share-based 
payments, granting of options or rights, restraint payments and 
all other benefits (including present values of existing future 
awards) (IoDSA 2009:par.180, own emphasis added).
King III, read together with the remuneration practice note 
(IoDSA 2013), requires disclosure of the fair value of share-
incentive grants, options or rights and specifies that this 
value should be based on the expected net present value of 
the instruments. This constitutes the grant date fair value of 
the instruments that is expected to vest. The practice note 
continues to state that best practice would be to disclose 
the ‘value at grant per grant’ (i.e. the grant date fair value), 
‘the value of all unvested/unexercised historical awards at 
current expected value’ (i.e. the reporting date fair value) and 
‘the value realized from all options exercised or share-based 
awards settled in the period under review’ (i.e. the gain on 
exercise). It is, therefore, submitted that ‘value’ in Section 
30(6)(e) should be interpreted as grant date fair value and, 
possibly, also reporting date fair value and gain on exercise.
Although the IFRS 2 expense is not the most likely 
interpretation of the term ‘value’ in the context of Section 
30(6)(e), as discussed, it is not ruled out as a useful value to 
disclose. According to Urson (2016), it should be mandatory 
for companies to make more comprehensive disclosure of 
their compensation schemes on a per director basis. He is 
of the opinion that companies should disclose both the gain 
on exercise of share options and the IFRS 2 expense on a per 
director basis, as this would grant shareholders the necessary 
flexibility to choose a metric for their own analysis, provide 
greater transparency and improve comparability, especially 
with international companies.
Current practice and illustration
From a preliminary inspection of companies’ annual financial 
statements, it seems that companies are disclosing the following 
values per director (Dippenaar & Steenkamp 2017):
•	 Grant date fair value (required by King III, read together 
with the remuneration practice note).
•	 Gain on exercise of share options only (previously 
required by the 1973 Act, although not required per 
director).
•	 Value of all share incentives exercised during the year 
(seemingly an extension of the 1973 Act’s requirement 
from options only to all share incentives).
•	 Sufficient information to calculate the value of all share 
incentives exercised.
•	 IFRS 2 expense (required by IAS 24 and IFRS 2, but not 
per director).
•	 A combination of the above.
Since only the grant date fair value is required to be disclosed 
per director, it is assumed that these other values noted are 
disclosed either voluntarily or in an attempt to comply with 
the Act. The uncertainty regarding which ‘value’ is required 
to be disclosed by Section 30(6)(e) and the inconsistent 
interpretations applied by companies lead to incomparability 
between similar companies.
The following example illustrates the differences in 
numbers that companies might disclose in their annual 
financial statements, depending on their interpretation of 
the term ‘value’ in Section 30(6)(e). These differences could 
be significant in bull or bear market conditions. For purposes 
of the illustration, a share option plan is used, where the 
directors have the option to purchase shares in future 
(during the exercise period), but at an exercise price equal 
to the share price on the grant date of the options. Share 
appreciation rights would be similar, except that the directors 
cannot purchase physical shares, but benefit by receiving 
cash for the increase in share price from grant date up to 
exercise date. In respect of plans where shares or phantom 
shares are granted, the vesting date and exercise date is the 
same; therefore, these types of plans were not selected to 
illustrate the full effect of the differences in interpretations of 
the term ‘value’.
Assume that Company X grants 100 share options to each of 
its 10 directors on 01 July 20×1. Company X has a 31 December 
reporting date. Each grant is conditional upon the director 
remaining in the service of Company X for another 3 years. 
In other words, the share options will vest on 30 June 20×4. 
The share options can be exercised at an exercise price of 
15 rand (R) at any time during the 6 years post vesting date, 
i.e. by 30 June 20×10.
The relevant fair values of the shares and share options, 
throughout the life of the share options, are presented in 
Table 6.
On the basis of a weighted average probability, Company X 
estimated on grant date that two of the directors would 
leave during the 3-year period and therefore forfeit their 
rights to the share options. This turned out to be true and 
eight directors’ share options vested on 30 June 20×4. Five 
directors exercised their share options on 30 June 20x8, 
while the other three directors’ options expired on 30 June 
20x10, since they were not exercised by that date. Company X 
TABLE 6: Fair values of shares and options throughout the life of the options.
Date Fair value per share Fair value per option
1 July 20×1 R15.00 R2.00
31 December 20×1 R15.10 R2.80
31 December 20×2 R15.80 R2.55
31 December 20×3 R16.20 R2.90
30 June 20×4 R15.50 R3.00
31 December 20×4 R17.00 R2.70
31 December 20×5 R17.10 R2.85
31 December 20×6 R17.50 R2.60
31 December 20×7 R16.40 R1.80
30 June 20×8 R16.00 R1.60
31 December 20×8 R16.50 R1.55
31 December 20×9 R16.90 R1.70
30 June 20×10 R17.20 R2.20
31 December 20×10 R18.00 N/A
N/A, not applicable
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could disclose the following amounts, per director, per year 
(in Table 7), in its annual financial statements, in respect 
of the ‘value’ of the SBPs. The information is presented 
for each of the financial years from 20x1 until 20x9 (at 31 
December each year) and for each of the possible 
interpretations of ‘value’ in Section 30(6)(e). No value will 
be disclosed in 20x10, as the options have expired. Values 
are rounded to the nearest rand and calculations for the 
values in Table 7 are provided in Appendix 1.
Conclusion and recommendations
The meaning of the term ‘value’, for the purposes of Section 
30(6)(e) of the Act, is unclear and can be interpreted in 
various ways, from variations of ‘gross’ values such as fair 
value on certain dates or even annualised values such as 
the IFRS 2 expense, to ‘net’ values such as the gain realised 
on exercise of SBPs or the intrinsic value thereof before 
exercise. Not only is it unclear if a gross or net value is 
implied, but if a gross value should be disclosed, then the 
date on which it should be determined is also uncertain. 
Since the meaning is unclear and the legislature’s intention 
is unknown, the author attempted to use logical reasoning 
in order to determine the most likely meaning. The term 
‘value’ is commonly understood as ‘the monetary worth’ of 
something. The author is of the opinion that it does not 
imply a net value like a gain on exercise of share options, as 
then surely the legislature would have used the existing 
wording in the 1973 Act. The fact that the wording was 
completely altered, shows that a different meaning should 
be ascribed to the term ‘value’ than gains on exercise of 
share options.
The author is of the opinion that a fair value should be 
disclosed, although it is uncertain why the legislature failed 
to use that exact term in Section 30(6)(e), seeing that ‘fair 
value’ is used 14 times in other sections of the Act. Fair value 
on grant date, reporting date, vesting date and exercise date 
would all be useful to disclose, but the author is of the opinion 
that it should be interpreted as the grant date fair value, as 
required by King III. It could even possibly be extended to 
also refer to the reporting date fair value and gain on exercise, 
which are stated as best practice in the King III practice note 
on remuneration.
The uncertainty regarding the meaning of ‘value’ in 
Section 30(6)(e) has significant consequences in terms of 
comparability of company annual financial statement 
disclosures and it is recommended that the wording of 
Section 30(6)(e) is amended to reflect the meaning intended 
by the legislature. It would be even more helpful if the Act 
could provide more detailed requirements of how particular 
components of remuneration should be calculated, as is the 
case in the United Kingdom in respect of quoted companies 
(United Kingdom 2013). It is also recommended that the Act 
is amended to be more prescriptive as to the format to be 
used for the disclosure, as was the case in the 1973 Act 
(which required the gain on exercise of options to be provided 
in a table format) and the United Kingdom, where Part 3 and 
Part 4 of the regulations to the Companies Act 2006 require 
disclosure of directors’ remuneration to be made graphically 
in bar graphs and tables (United Kingdom 2013). This would 
enhance the comparability of companies’ disclosures. Other 
studies (Asafo-Adjei 2015; Madlela & Cassim 2017) have also 
found that the Act’s minimum standards of remuneration 
disclosure are too low and agree that the Act should 
standardise the disclosure of directors’ remuneration, similar 
to that of the United Kingdom.
The level of disclosure of directors’ remuneration by 
companies is still a problem for shareholders and users of 
financial statements. In order to help address this problem 
and to assist companies with the preparation of their 
disclosures, especially those that need to be disclosed per 
director, as required by so many different sources, future 
research could include the development of an easy-to-use 
disclosure checklist.
Fair value could be determined using a variety of valuation 
techniques. The study is limited as it does not attempt to 
evaluate valuation techniques nor to prescribe the most 
appropriate valuation method to determine the fair value of 
share-based remuneration. A future research study could 
consider the appropriateness of different valuation methods 
TABLE 7: Disclosures of share-based payment ‘value’, per director, in the 20x1 to 20x9 financial statements of Company X.
Reporting date Fair value on  
grant date
Fair value on  
vesting date
Fair value at  
reporting date
Gain on exercise IFRS 2 expense Intrinsic value on 
reporting date
20×1 R200a – R280a – R33e R10a
20×2 – – R255a – R67e R80a
20×3 – – R290a – R67e R120a
20×4 – R300b R270b – R33e R200b
20×5 – – R285b – – R210b
20×6 – – R260b – – R250b
20×7 – – R180b – – R140b
20×8 – – R155c R100d – R150c
20×9 – – R170c – – R190c
a, This disclosure can also vary in practice. Some could disclose this value in respect of each of the 10 directors that received a grant, while others could disclose it for each director that the company 
expects will remain in service until the vesting date (i.e. only eight directors).
b, This would be disclosed in respect of each of the eight directors in which the rights vested.
c, This value is disclosed for each of the three directors that had not exercised their rights at that date.
d, The gain is disclosed for each of the five directors that exercised their rights during the year.
e, The IFRS 2 expense is calculated based on the number of directors expected to meet the vesting conditions and is therefore disclosed in respect of each of the eight directors expected to remain 
in service until the vesting date.
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available or applied by companies to value their share-based 
incentives.
Acknowledgements
Competing interests
The author declares that she has no financial or personal 
relationships that may have inappropriately influenced her 
in writing this article.
References
Asafo-Adjei, M.A., 2015, ‘Regulation of executive directors remuneration in South 
Africa: The road to achieving good corporate governance’, master’s thesis, 
University of Cape Town, Cape Town.
Collins English Dictionary, 2017, viewed 22 May 2017, from https://www.
collinsdictionary.com/dictionary/english/value
Devenish, G.E., 1992, Interpretation of statutes, Juta & Co., Ltd., Cape Town.
De Ville, J.R., 2000, Constitutional & statutory interpretation, Interdoc Consultants Pty 
Ltd, Cape Town.
Dippenaar, M. & Steenkamp, G., 2017, ‘Disclosure of directors’ remuneration’, 
Accountancy SA, November 2017, 54–56.
Hutchinson, T. & Duncan, N., 2012, ‘Defining and describing what we do: Doctrinal 
legal research’, Deakin Law Review 17(1), 83–119. https://doi.org/10.21153/
dlr2012vol17no1art70
IFRS Foundation, 2016, A guide through international financial reporting standards, 
parts A1, A2, B1 and B2, IFRS Foundation, London.
Institute of Directors Southern Africa (IoDSA), 2009, King report on governance for 
South Africa 2009, IoDSA, Johannesburg.
Institute of Directors Southern Africa (IoDSA), 2013, Practice notes – A guide to the 
application of King III: Remuneration, IoDSA, Johannesburg.
Institute of Directors Southern Africa (IoDSA), 2016, King IV report on corporate 
governance for South Africa 2016, IoDSA, Johannesburg.
Jaga v Dönges NO 1950 (4) SA 653 (A) 662
JSE Limited (JSE), 2017, JSE Limited listing requirements, viewed 26 May 2017, from 
https://www.jse.co.za/content/JSERulesPoliciesandRegulationItems/JSE%20
Listings%20Requirements.pdf
Madlela, V. & Cassim, R., 2017, ‘Disclosure of directors’ remuneration under South 
African company law: Is it adequate?’, South African Law Journal 134(2), 383–414.
Massie, K., Collier, D. & Crotty, A., 2014, Executive salaries in South Africa: Who should 
have a say on pay?, Jacana Media, Auckland Park.
Mavrodinov, N., 2012, ‘The changing landscape of long-term share-based 
compensation in South Africa’, master’s thesis, University of Cape Town, 
Cape Town.
Ngcobo and Others v Salimba CC; Ngcobo v Van Rensburg 1999 (2) SA 1057 (SCA)
Oxford English Dictionary online version, 2017, viewed 22 May 2017, from http://
www.oed.com/view/Entry/221253?rskey=LcoFKv&result=1#eid
PricewaterhouseCooper Inc. (PWC), 2015, Executive directors practices and 
remuneration trends report, 7th edn., South Africa, viewed 02 June 2017, from 
https://www.pwc.co.za/en/assets/pdf/executive-directors-report07.2015.pdf
Republic of South Africa, 1973, Companies Act 61 of 1973, Government Printer, 
Pretoria.
Republic of South Africa, 1999a, Companies Amendment Act 37 of 1999, Government 
Printer, Pretoria.
Republic of South Africa, 1999b, Companies Amendment Bill, Government Printer, 
Pretoria.
Republic of South Africa, 2007, Companies Bill, Government Printer, Pretoria.
Republic of South Africa, 2008, Companies Act 71 of 2008, Government Printer, 
Pretoria.
Steyn, F. & Cairney, C., 2016, ‘MAF 08: Long-term incentives: Do shareholders get 
what they pay for?’, in Southern African Accounting Association National Teaching 
and Learning and Regional Conference Proceedings, Cape Town, South Africa, 02 
September, pp. 244–267.
Steyn, G.F., 2015, ‘The relationship between CEO compensation and future share 
returns in South Africa’, master’s thesis, University of Western Cape, Cape Town.
Thornton, G.C., 1996, Legislative Drafting, 4th edn., Tottel Publishing, United Kingdom.
United Kingdom, 2006, Companies Act 2006, viewed 09 June 2017, from http://www.
legislation.gov.uk/ukpga/2006/46/section/421
United Kingdom, 2013, Large and medium-sized companies and groups (accounts and 
reports) (amendments) regulations 2013 no. 1981, viewed 09 June 2017, from 
http://www.legislation.gov.uk/uksi/2013/1981/pdfs/uksi_20131981_en.pdf
Urson, M., 2016, ‘CEO pay ratios and company performance: A study of JSE-listed 
consumer goods and services companies’, master’s thesis, University of Cape 
Town, Cape Town.
Venter v R [1907] TS 910
Voller, R., (Acting Commissioner of Companies and Intellectual Property Commission), 
2016, Notice no. 20 to customers: Non-disclosure of remuneration and benefits of 
directors and prescribed officers in annual financial statements, 14 March 2016, 
viewed 09 June 2017, from http://www.cipc.co.za/files/8414/5796/3772/
Notice_20_of_2016.pdf
Webster’s New World College Dictionary, 4th edn., n.d., viewed 22 May 2017, from 
http://www.yourdictionary.com/value#websters
Appendix starts on the next page →
Page 9 of 9 Original Research
http://www.sajems.org Open Access
TABLE 1-A1: Calculations of values disclosed in Table 7.
Reporting date Fair value on  
grant date
Fair value on  
vesting date
Fair value at  
reporting date
Gain on exercise IFRS 2 expense Intrinsic value on  
reporting date
20×1 R2 × 100 – R2.80 × 100 – 100 × R2 × 6/36 (R15.10 – 15) × 100
20×2 – – R2.55 × 100 – 100 × R2 × 12/36 (R15.80 – 15) × 100
20×3 – – R2.90 × 100 – 100 × R2 × 12/36 (R16.20 – 15) × 100
20×4 – R3 × 100 R2.70 × 100 – 100 × R2 × 6/36 (R17.00 – 15) × 100
20×5 – – R2.85 × 100 – – (R17.10 – 15) × 100
20×6 – – R2.60 × 100 – – (R17.50 – 15) × 100
20×7 – – R1.80 × 100 – – (R16.40 – 15) × 100
20×8 – – R1.55 × 100 (R16 – 15) × 100 – (R16.50 – 15) × 100
20×9 – – R1.70 × 100 – – (R16.90 – 15) × 100
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